ADI MOR

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Chemomab Therapeutics Ltd.

Filing Date Source Excerpt
2021-09-17 “Dr. Mor has in-depth knowledge in immunology… [and] received her Ph.D. in immunology from Tel Aviv University in the Department of Neurobiochemistry.”

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-10-08